IN2013CN00536A - - Google Patents

Info

Publication number
IN2013CN00536A
IN2013CN00536A IN536CHN2013A IN2013CN00536A IN 2013CN00536 A IN2013CN00536 A IN 2013CN00536A IN 536CHN2013 A IN536CHN2013 A IN 536CHN2013A IN 2013CN00536 A IN2013CN00536 A IN 2013CN00536A
Authority
IN
India
Prior art keywords
protein
hpv52
truncated
vlp
infection
Prior art date
Application number
Inventor
Shaowei Li
Xiaobing Mo
Minxi Wei
Huirong Pan
Jun Zhang
Ningshao Xia
Original Assignee
Univ Xiamen
Xiamen Innovax Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Xiamen, Xiamen Innovax Biotech Co Ltd filed Critical Univ Xiamen
Publication of IN2013CN00536A publication Critical patent/IN2013CN00536A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20051—Methods of production or purification of viral material

Abstract

Provided is a truncated L1 protein of human papillomavirus (HPV) type 52 which compared to a wild type HPV52 L1 protein is truncated by 27 42 amino acids at the N terminal. Also provided are a coding sequence of the truncated HPV52 L1 protein a virus like particle (VLP) comprising the protein and a method of preparing the protein and the VLP using an Escherichia coli expression system. The truncated HPV52 L1 protein and an assembled VLP can be used to prevent an HPV52 infection and HPV52 infection induced diseases such as cervical cancer.
IN536CHN2013 2010-07-02 2011-07-01 IN2013CN00536A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010216189 2010-07-02
PCT/CN2011/076763 WO2012000454A1 (en) 2010-07-02 2011-07-01 Truncated l1 protein of human papillomavirus type 52

Publications (1)

Publication Number Publication Date
IN2013CN00536A true IN2013CN00536A (en) 2015-07-03

Family

ID=45050553

Family Applications (1)

Application Number Title Priority Date Filing Date
IN536CHN2013 IN2013CN00536A (en) 2010-07-02 2011-07-01

Country Status (7)

Country Link
US (1) US9499591B2 (en)
EP (1) EP2589604B1 (en)
CN (1) CN102268076B (en)
BR (1) BR112013000031A2 (en)
DK (1) DK2589604T3 (en)
IN (1) IN2013CN00536A (en)
WO (1) WO2012000454A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103044531B (en) * 2012-09-29 2014-07-30 重庆原伦生物科技有限公司 Purification method of methicillin-resistant staphylococcus aureus (MREA)-resistant vaccine recombinant protein antigen HI2
CN106701796B (en) * 2015-08-12 2021-11-16 北京康乐卫士生物技术股份有限公司 52 type recombinant human papilloma virus-like particle and preparation method thereof
CN105985934A (en) * 2015-08-18 2016-10-05 北京康乐卫士生物技术股份有限公司 Divalent, trivalent or multivalent HPV pseudovirus and application thereof
JP6958818B2 (en) 2015-12-04 2021-11-02 シアメン ユニバーシティＸｉａｍｅｎ Ｕｎｉｖｅｒｓｉｔｙ Mutation of L1 protein of human papillomavirus type 58
CN106831959B (en) * 2015-12-04 2019-11-05 厦门大学 A kind of mutant of human papillomavirus 33 type L 1 protein
CN107557347B (en) * 2016-06-30 2022-03-29 中国科学院上海巴斯德研究所 Novel enterovirus 71-type virus-like particle, preparation method and application thereof
CN114174319A (en) * 2019-07-19 2022-03-11 神州细胞工程有限公司 Chimeric human papilloma virus type 52L 1 protein
BR112022001070A2 (en) * 2019-07-19 2022-04-19 Sinocelltech Ltd Polyvalent immunogenicity composition for human papillomavirus
CN114539365B (en) * 2020-11-26 2023-12-01 中国医学科学院基础医学研究所 Modified human papilloma virus 52 type L1 protein and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551597B1 (en) 1999-03-18 2003-04-22 President & Fellows Of Harvard College Vaccine compositions for human papillomavirus
CN1293093C (en) * 2002-08-30 2007-01-03 马润林 Pronucleus preparation of nipple tumour virus capsid protein and application
PL1730175T3 (en) 2004-03-24 2010-09-30 Merck Sharp & Dohme Optimized expression of hpv 52 l1 in yeast
CN101153280B (en) * 2006-09-29 2015-08-19 厦门大学 The method of purifying human papilloma virus advanced protein L1 from prokaryotic organism
BRPI0815818A2 (en) 2007-04-29 2016-08-02 Beijing Wantai Biological Pharmacy Entpr Co Ltd human papilloma virus type 18 truncated l1 protein
DK2154147T3 (en) 2007-04-29 2015-12-07 Beijing Wantai Biological Pharmacy Entpr Co Ltd Truncated L1 protein of human papillomavirus 16
DK2910566T5 (en) 2007-05-29 2016-11-07 Univ Xiamen Truncated L1 protein of human papillomavirus 11
WO2008145021A1 (en) 2007-05-29 2008-12-04 Xiamen University A truncated l1 protein of human papillomavirus 6

Also Published As

Publication number Publication date
CN102268076B (en) 2017-04-26
EP2589604A1 (en) 2013-05-08
US9499591B2 (en) 2016-11-22
CN102268076A (en) 2011-12-07
DK2589604T3 (en) 2017-01-16
WO2012000454A1 (en) 2012-01-05
EP2589604A4 (en) 2013-12-18
EP2589604B1 (en) 2016-10-05
BR112013000031A2 (en) 2016-05-10
US20130230548A1 (en) 2013-09-05

Similar Documents

Publication Publication Date Title
IN2013CN00536A (en)
EA201190327A1 (en) NEW CONSTRUCTIONS OF HUMAN PAPILLOMA VIRUS PROTECTION (HPV) AND THEIR APPLICATION IN THE PREVENTION OF DISEASE CAUSED BY HPV
TR201908199T4 (en) Vaccines against HPV.
BR112015021974A2 (en) COMPOSITION AND METHOD OF INDUCING AN IMMUNE RESPONSE
CA2817005A1 (en) Rabies glycoprotein virus-like particles (vlps)
MX2011007692A (en) Improved vaccines for human papilloma virus and methods for using the same.
WO2007095320A3 (en) Hpv antigens, vaccine compositions, and related methods
MX2017005788A (en) Therapeutic hpv16 vaccines.
EP2568289A3 (en) Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
MY184076A (en) Hpv chimaeric particle
MX2011007307A (en) Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by the same.
WO2008034388A8 (en) Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
WO2007121895A3 (en) Hpv-16-based papillomavirus vaccine
NZ702146A (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
MX361408B (en) A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv.
GB201019240D0 (en) Respiratory syncytical virus vaccine
DE602005019238D1 (en) OTEINEN
MX2013013228A (en) Virus-like particles and process for preparing same.
PH12020552219A1 (en) Influenza virus hemagglutinin mutants
WO2013055326A3 (en) Vaccines for human papilloma virus and methods for using the same
EP2593548A4 (en) Human papillomavirus e7 antigen compositions and uses thereof
UA98254C2 (en) mucosal vaccine for immune therapy of diseases conditioned by human papilloma viruses
WO2010147971A3 (en) Il23 modified viral vector for recombinant vaccines and tumor treatment
AR077398A2 (en) SIMILAR PARTICLES TO VIRUSES OF HPV31 (HUMAN PAPILOMA VIRUS). METHOD FOR PRODUCERS, VACCINE AND COMPOSITION THAT CONTAIN THEM
EA200702077A1 (en) VACCINE